Actavis is committed to providing its customers with a wide range of affordable, high-quality products covering all significant therapeutic classes. 

The US division product list contains more than 80 currently marketed molecules presented in a wide range of dosage forms including: tablets, capsules, liquids, cream, ointments, suppositories, and injectables.  Our robust product pipeline and significant investment in research and development  assures that we will continue to introduce the latest high-quality generic products to the market.